trihexyphenidyl has been researched along with Cardiovascular Diseases in 2 studies
Trihexyphenidyl: One of the centrally acting MUSCARINIC ANTAGONISTS used for treatment of PARKINSONIAN DISORDERS and drug-induced extrapyramidal movement disorders and as an antispasmodic.
Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Harmine is a β-carboline alkaloid that displays antidepressant, antitumor and other pharmacological effects." | 1.62 | Central inhibition prevents the in vivo acute toxicity of harmine in mice. ( Gao, S; Li, J; Li, X; Liang, H; Lv, Y; Tang, X; Wang, M; Xiao, L; Zhang, J; Zou, H, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lv, Y | 1 |
| Liang, H | 1 |
| Li, J | 1 |
| Li, X | 1 |
| Tang, X | 1 |
| Gao, S | 1 |
| Zou, H | 1 |
| Zhang, J | 1 |
| Wang, M | 1 |
| Xiao, L | 1 |
| Pomara, N | 1 |
| Sidtis, J | 1 |
2 other studies available for trihexyphenidyl and Cardiovascular Diseases
| Article | Year |
|---|---|
Central inhibition prevents the in vivo acute toxicity of harmine in mice.
Topics: Acetylcholinesterase; Anesthetics; Animals; Cardiovascular Diseases; Central Nervous System Diseases | 2021 |
Apolipoprotein E epsilon4 and anticholinergic cognitive toxicity.
Topics: Aged; Alleles; Apolipoprotein E4; Cardiovascular Diseases; Cholinergic Antagonists; Cognition Disord | 2009 |